The aXess graft (Xeltis) is a synthetic bioresorbable vascular conduit under investigation to establish arteriovenous access for hemodialysis in patients with end-stage renal disease.
The aXess graft (Xeltis) is a synthetic bioresorbable vascular conduit under investigation to establish arteriovenous access for hemodialysis in patients with end-stage renal disease.
Hayes Report Sale Policy: Hayes will review your request to purchase a report and respond to you. Individuals requesting reports due to a payment denial should contact the involved health insurer for details and information.
Please contact us if you are interested in a Hayes subscription.
Learn more about our Privacy Policy
This site uses cookies. By continuing to use this website, you agree to their use. For details, please review our Privacy Policy